XML 31 R9.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Cash, cash equivalents and short-term investments | 6 Months Ended
--- | ---
Jun. 30, 2013
Cash, cash equivalents and short-term investments |
Cash, cash equivalents and short-term investments | 4. Cash, cash equivalents and short-term investments The following tables summarize our cash, cash equivalents and marketable securities at June 30, 2013 and December 31, 2012 (in thousands):
As of June 30, 2013 |  | Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |
Cash and money market funds |  | $ | 28,193 |  | $ | — |  | $ | — |  | $ | 28,193 |
Corporate debt securities |  |  |  |  |  |  |  |  |
Due in one year or less |  | 20,251 |  | 1 |  | (16 | ) | 20,236 |
Due in two years or less |  | 5,927 |  | — |  | (11 | ) | 5,916 |
Total |  | $ | 54,371 |  | $ | 1 |  | $ | (27 | ) | $ | 54,345 |
Reported as: |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 28,193 |  | $ | — |  | $ | — |  | $ | 28,193 |
Short-term investments |  | 26,178 |  | 1 |  | (27 | ) | 26,152 |
Total |  | $ | 54,371 |  | $ | 1 |  | $ | (27 | ) | $ | 54,345 |
As of December 31, 2012 |  | Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |
Cash and money market funds |  | $ | 14,776 |  | $ | — |  | $ | — |  | $ | 14,776 |
Corporate debt securities |  |  |  |  |  |  |  |  |
Due in one year or less |  | 5,754 |  | 2 |  | (1 | ) | 5,755 |
Due in two years or less |  | 10,867 |  | 3 |  | (10 | ) | 10,860 |
Total |  | $ | 31,397 |  | $ | 5 |  | $ | (11 | ) | $ | 31,391 |
Reported as: |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 14,776 |  | $ | — |  | $ | — |  | $ | 14,776 |
Marketable securities |  | 16,621 |  | 5 |  | (11 | ) | 16,615 |
Total |  | $ | 31,397 |  | $ | 5 |  | $ | (11 | ) | $ | 31,391 |
We held 21 debt securities at June 30, 2013 that had been in an unrealized loss position for less than 12 months. We held no investments that have been in a continuous unrealized loss position for 12 months or longer. The fair value on these securities was $20.2 million. We evaluated our securities for other-than-temporary impairments based on quantitative and qualitative factors. We considered the decline in market value for these 21 securities to be primarily attributable to current economic and market conditions. It is not more likely than not that we will be required to sell these securities, and we do not intend to sell these securities before the recovery of their amortized cost bases, which recovery is expected within the next 12 months. Based on our analysis, we do not consider these investments to be other-than-temporarily impaired as of June 30, 2013. As of June 30, 2013, we held $13.3 million in financial institution debt securities and other corporate debt securities located in Canada, the United Kingdom, the Netherlands, Australia, and Norway. Based on our analysis, we do not consider these investments to be other-than-temporarily impaired as of June 30, 2013. We had no material realized gains or losses on our short-term investments for the three months and six months ended June 30, 2013 and 2012. There were no other-than-temporary impairments recognized for the three months and six months ended June 30, 2013 and 2012.

X
- Details
Name: | ovas_CashCashEquivalentsAndMarketableSecuritiesAbstract
Namespace Prefix: | ovas_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss). + References No definition available. + Details
Name: | us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration